Akt Activates the Mammalian Target of Rapamycin by Regulating Cellular ATP Level and AMPK Activity
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
The serine/threonine kinase Akt is an upstream positive regulator of the mammalian target of rapamycin (mTOR). However, the mechanism by which Akt activates mTOR is not fully understood. The known pathway by which Akt activates mTOR is via direct phosphorylation and inhibition of tuberous sclerosis complex 2 (TSC2), which is a negative regulator of mTOR. Here we establish an additional pathway by which Akt inhibits TSC2 and activates mTOR. We provide for the first time genetic evidence that Akt regulates intracellular ATP level and demonstrate that Akt is a negative regulator of the AMP-activated protein kinase (AMPK), which is an activator of TSC2. We show that in Akt1/Akt2 DKO cells AMP/ATP ratio is markedly elevated with concomitant increase in AMPK activity, whereas in cells expressing activated Akt there is a dramatic decrease in AMP/ATP ratio and a decline in AMPK activity. Currently, the Akt-mediated phosphorylation of TSC2 and the inhibition of AMPK-mediated phosphorylation of TSC2 are viewed as two separate pathways, which activate mTOR. Our results demonstrate that Akt lies upstream of these two pathways and induces full inhibition of TSC2 and activation of mTOR both through direct phosphorylation and by inhibition of AMPK-mediated phosphorylation of TSC2. We propose that the activation of mTOR by Akt-mediated cellular energy and inhibition of AMPK is the predominant pathway by which Akt activates mTOR in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AKT positively regulates mTOR (activator of PGC-1α) by direct inhibition of the inhibitory complex TSC1/2 and by inhibition of the mTOR inhibitors AMPK (activator of PGC-1α) and GSK3b (regulator of PGC-1α turnover) [67, 70].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
Self-citationTSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,656
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
THE AMP-ACTIVATED/SNF1 PROTEIN KINASE SUBFAMILY: Metabolic Sensors of the Eukaryotic Cell?
Hardie, D. G., Carling, D., & Carlson, M. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.821 · Cited by 1,435
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D., & Hardie, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27879 · Cited by 1,264
Research works printed but not linked: 3
- Sapkota, 2002, Biochem. J., 362, 481, 10.1042/bj3620481 · doi:10.1042/bj3620481
- Sekulic, 2000, Cancer Res., 60, 3504
- Parsons, 2003, Methods Mol. Biol., 222, 147
Cited by
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
Shackelford, D. B., & Shaw, R. J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2676 · Cited by 1,943
“Although TSC2 is clearly a central receiver of inputs that regulate mTORC1, cells lacking TSC2 still partially suppress mTORC1 following AMPK activatio”
BackgroundGrowing roles for the mTOR pathway
Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.009 · Cited by 1,560
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Haar, E. V., Lee, S.-I., Bandhakavi, S., Griffin, T. J., & Kim, D.-H. (2007) · Nature Cell Biology · doi:10.1038/ncb1547 · Cited by 1,190
Liang, J., Shao, S. H., Xu, Z.-X., Hennessy, B., Ding, Z., Larrea, M., Kondo, S., Dumont, D. J., Gutterman, J. U., Walker, C. L., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1537 · Cited by 866
The mTOR Signalling Pathway in Human Cancer
Pópulo, H., Lopes, J. M., & Soares, P. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021886 · Cited by 830
“leading to the inhibition of TSC2 and the activation of mTORC1 [71].”
BackgroundThe Akt-mTOR tango and its relevance to cancer
Hay, N. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.008 · Cited by 821
Self-citationBhaskar, P. T., & Hay, N. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.03.020 · Cited by 798
Self-citationNogueira, V., Park, Y., Chen, C.-C., Xu, P.-Z., Chen, M.-L., Tonic, I., Unterman, T., & Hay, N. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.003 · Cited by 780
Self-citationThe Molecular Bases of Training Adaptation
Coffey, V. G., & Hawley, J. A. (2007) · Sports Medicine · doi:10.2165/00007256-200737090-00001 · Cited by 756
Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
Dan, H. C., Cooper, M. J., Cogswell, P. C., Duncan, J. A., Ting, J. P.-Y., & Baldwin, A. S. (2008) · Genes & Development · doi:10.1101/gad.1662308 · Cited by 636
LKB1 and AMP-activated protein kinase control of mTOR signalling and growth
Shaw, R. J. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01972.x · Cited by 644
“While TSC2 is clearly a central receiver of a wide variety of positive and negative inputs that regulate mTORC1, cells lacking TSC2 still partially suppress mTORC1 following AMPK activation (albeit less so than wild-type cells), suggesting that additional AMPK substrates may directly or indirectly modulate mTORC1 acti…”
BackgroundIncreased lipogenesis in cancer cells: new players, novel targets
Swinnen, J. V., Brusselmans, K., & Verhoeven, G. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232894.28674.30 · Cited by 610
Dreyer, H. C., Fujita, S., Cadenas, J. G., Chinkes, D. L., Volpi, E., & Rasmussen, B. B. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.113175 · Cited by 570
Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
Robey, R. B., & Hay, N. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.010 · Cited by 540
Self-citationShaw, R. J. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.10.005 · Cited by 550
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt
Robey, R. B., & Hay, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209595 · Cited by 536
Self-citationGlutathione primes t cell metabolism for inflammation
Mak, T. W., Grusdat, M., Duncan, G. S., Dostert, C., Nonnenmacher, Y., Cox, M., Binsfeld, C., Hao, Z., Brüstle, A., Itsumi, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.019 · Cited by 511
Dzeja, P., & Terzic, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10041729 · Cited by 475
Gozuacik, D., & Kimchi, A. (2007) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)78006-1 · Cited by 437
The tuberous sclerosis complex
Orlova, K. A., & Crino, P. B. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05117.x · Cited by 401
Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway
Zhang, H. H., Huang, J., Düvel, K., Boback, B., Wu, S., Squillace, R. M., Wu, C.-L., & Manning, B. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006189 · Cited by 399
Molecular neurobiology of mTOR
Switon, K., Kotulska, K., Janusz-Kaminska, A., Zmorzynska, J., & Jaworski, J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.017 · Cited by 387
Nutrient acquisition strategies of mammalian cells
Palm, W., & Thompson, C. B. (2017) · Nature · doi:10.1038/nature22379 · Cited by 388
AMPK inhibition in health and disease
Viollet, B., Horman, S., Leclerc, J., Lantier, L., Foretz, M., Billaud, M., Giri, S., & Andreelli, F. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.488215 · Cited by 383
FoxOs Inhibit mTORC1 and Activate Akt by Inducing the Expression of Sestrin3 and Rictor
Chen, C.-C., Jeon, S.-M., Bhaskar, P. T., Nogueira, V., Sundararajan, D., Tonic, I., Park, Y., & Hay, N. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.03.008 · Cited by 368
Self-citationRegulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway
Shiojima, I., & Walsh, K. (2006) · Genes & Development · doi:10.1101/gad.1492806 · Cited by 356
Fyfe, J. J., Bishop, D. J., & Stepto, N. K. (2014) · Sports Medicine · doi:10.1007/s40279-014-0162-1 · Cited by 347
“This effect is opposed by Akt, which phosphorylates and inactivates TSC2, alleviating its inhibition of mTORC1 [90, 95].”
Targeting the mTOR signaling network in cancer
Chiang, G. G., & Abraham, R. T. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.08.001 · Cited by 327
Interplay between FOXO, TOR, and Akt
Hay, N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.03.013 · Cited by 311
Self-citationCross-Talk between AMPK and mTOR in Regulating Energy Balance
Xu, J., Ji, J., & Yan, X.-H. (2012) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.500245 · Cited by 299
Metabolic regulation of NLRP 3
Hughes, M. M., & O'Neill, L. A. J. (2018) · Immunological Reviews · doi:10.1111/imr.12608 · Cited by 311
Reiling, J. H., & Sabatini, D. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209889 · Cited by 311
Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase
Avruch, J., Hara, K., Lin, Y., Liu, M., Long, X., Ortiz-Vega, S., & Yonezawa, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209882 · Cited by 296
The muscle fiber type–fiber size paradox: hypertrophy or oxidative metabolism?
van Wessel, T., de Haan, A., van der Laarse, W. J., & Jaspers, R. T. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1545-0 · Cited by 287
The role of skeletal muscle mTOR in the regulation of mechanical load‐induced growth
Goodman, C. A., Frey, J. W., Mabrey, D. M., Jacobs, B. L., Lincoln, H. C., You, J., & Hornberger, T. A. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.218255 · Cited by 297
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Querfurth, H., & Lee, H.-K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00428-5 · Cited by 288
mTOR: A pathogenic signaling pathway in developmental brain malformations
Crino, P. B. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.07.008 · Cited by 266
Heat shock response and autophagy—cooperation and control
Dokladny, K., Myers, O. B., & Moseley, P. L. (2015) · Autophagy · doi:10.1080/15548627.2015.1009776 · Cited by 255
Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms
Dunlop, E. A., & Tee, A. R. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.012 · Cited by 258
AMPK signaling and its targeting in cancer progression and treatment
Hsu, C.-C., Peng, D., Cai, Z., & Lin, H.-K. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.006 · Cited by 246
AMPK: A Contextual Oncogene or Tumor Suppressor?
Liang, J., & Mills, G. B. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3876 · Cited by 252
Phycocyanin: A Potential Drug for Cancer Treatment
Jiang, L., Wang, Y., Yin, Q., Liu, G., Liu, H., Huang, Y., & Li, B. (2017) · Journal of Cancer · doi:10.7150/jca.21058 · Cited by 238
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK
Cheng, Z., Pang, T., Gu, M., Gao, A.-H., Xie, C.-M., Li, J.-Y., Nan, F.-J., & Li, J. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.09.007 · Cited by 240
Skeen, J. E., Bhaskar, P. T., Chen, C.-C., Chen, W. S., Peng, X.-D., Nogueira, V., Hahn-Windgassen, A., Kiyokawa, H., & Hay, N. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.022 · Cited by 234
Self-citationThe TOR signalling network from yeast to man
De Virgilio, C., & Loewith, R. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.02.013 · Cited by 227
Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis
Ong, C. W. M., Elkington, P. T., Brilha, S., Ugarte-Gil, C., Tome-Esteban, M. T., Tezera, L. B., Pabisiak, P. J., Moores, R. C., Sathyamoorthy, T., Patel, V., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004917 · Cited by 233
Lee, S.-Y., Lee, S. H., Yang, E.-J., Kim, E.-K., Kim, J.-K., Shin, D.-Y., & Cho, M.-L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135858 · Cited by 225
Role of IGF-I in skeletal muscle mass maintenance
Clemmons, D. R. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.04.002 · Cited by 218
Autophagic dysregulation in doxorubicin cardiomyopathy
Bartlett, J. J., Trivedi, P. C., & Pulinilkunnil, T. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.01.007 · Cited by 214
DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses
Vasseur, S., Afzal, S., Tardivel-Lacombe, J., Park, D. S., Iovanna, J. L., & Mak, T. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812745106 · Cited by 216
Roberts, M. D., McCarthy, J. J., Hornberger, T. A., Phillips, S. M., Mackey, A. L., Nader, G. A., Boppart, M. D., Kavazis, A. N., Reidy, P. T., Ogasawara, R., et al. (2023) · Physiological Reviews · doi:10.1152/physrev.00039.2022 · Cited by 214
Chapter 1 Physiological Roles of Ribosomal Protein S6: One of Its Kind
(2008) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(08)00801-0 · Cited by 212
PIM kinase (and Akt) biology and signaling in tumors
Warfel, N. A., & Kraft, A. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.03.001 · Cited by 204
Goncharov, D. A., Kudryashova, T. V., Ziai, H., Ihida-Stansbury, K., DeLisser, H., Krymskaya, V. P., Tuder, R. M., Kawut, S. M., & Goncharova, E. A. (2014) · Circulation · doi:10.1161/circulationaha.113.004581 · Cited by 200
Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders
Maiese, K. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12804 · Cited by 199
Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass
Frost, R. A., & Lang, C. H. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00089.2007 · Cited by 200
Phosphoinositide-3 Kinase-Akt Pathway Controls Cellular Entry of Ebola Virus
Saeed, M. F., Kolokoltsov, A. A., Freiberg, A. N., Holbrook, M. R., & Davey, R. A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000141 · Cited by 198
“mTOR, being a positive regulator of translation [28], could potentially stimulate synthesis of factors needed during entry.”
BackgroundRoles of AMP-activated Protein Kinase in Alzheimer’s Disease
Cai, Z., Yan, L.-J., Li, K., Quazi, S. H., & Zhao, B. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8173-2 · Cited by 193
Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling
Packer, L., & Cadenas, E. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-005fr · Cited by 187
Ma, T., Chen, Y., Vingtdeux, V., Zhao, H., Viollet, B., Marambaud, P., & Klann, E. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1694-14.2014 · Cited by 191
“AMPK is activated by either binding of AMP with the -subunit or phosphorylation of the -subunit at Thr172; the latter is quantitatively more important for enzymatic activity (Hardie, 2004).”
BackgroundInfluentialKhan, N., Afaq, F., Kweon, M.-H., Kim, K., & Mukhtar, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3941 · Cited by 185
Aguilar, V., Alliouachene, S., Sotiropoulos, A., Sobering, A., Athea, Y., Djouadi, F., Miraux, S., Thiaudière, E., Foretz, M., Viollet, B., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.006 · Cited by 183
Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
Singh, S. S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12261 · Cited by 179
Hua, Y., Zhang, Y., Ceylan-Isik, A. F., Wold, L. E., Nunn, J. M., & Ren, J. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0222-8 · Cited by 178
Post-transcriptional coordination of immunological responses by RNA-binding proteins
Kafasla, P., Skliris, A., & Kontoyiannis, D. L. (2014) · Nature Immunology · doi:10.1038/ni.2884 · Cited by 180
Yeo, E.-J. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0233-3 · Cited by 175
Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress
Huang, D., Li, T., Wang, L., Zhang, L., Yan, R., Li, K., Xing, S., Wu, G., Hu, L., Jia, W., et al. (2016) · Cell Research · doi:10.1038/cr.2016.109 · Cited by 170
Adams, C. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610510200 · Cited by 169
Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle
Hornberger, T. A. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.05.007 · Cited by 170
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript TSC1/2 -| Rheb → mTORC1 pathway (Hahn-Windgassen et al., 2005).”
BackgroundFunctional and Phenotypic Plasticity of CD4+T Cell Subsets
Caza, T. N., & LANDAS, S. K. (2015) · BioMed Research International · doi:10.1155/2015/521957 · Cited by 206
Dhanya, R., Arya, A. D., Nisha, P., & Jayamurthy, P. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00336 · Cited by 167
“Precipitated salt was separated by centrifugation at 13000 × g for 10 min at 4◦C. Aliquoted samples were stored at −80◦C. Adenine nucleotide measurements were conducted by HPLC with a Phenomenex Gemini column (5mm, 0.46 cm × 15 cm, C18 110A) as previously described (Hahn-Windgassen et al., 2005).”
MethodInfluentialKim, S. K., & Novak, R. F. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.07.004 · Cited by 167
Cordycepin Inhibits Protein Synthesis and Cell Adhesion through Effects on Signal Transduction
Wong, Y. Y., Moon, A., Duffin, R., Barthet-Barateig, A., Meijer, H. A., Clemens, M. J., & de Moor, C. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.071159 · Cited by 163
Cuthbertson, D. J., Babraj, J., Smith, K., Wilkes, E., Fedele, M. J., Esser, K., & Rennie, M. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00415.2005 · Cited by 166
Ralph, S. J., Rodríguez-Enríquez, S., Neuzil, J., & Moreno-Sánchez, R. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.12.006 · Cited by 165
PGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
“AKT positively regulates mTOR (activator of PGC-1α) by direct inhibition of the inhibitory complex TSC1/2 and by inhibition of the mTOR inhibitors AMPK (activator of PGC-1α) and GSK3b (regulator of PGC-1α turnover) [67,70].”
Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
Shang, R.-Z., Qu, S.-B., & Wang, D.-S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i45.9933 · Cited by 162
Thomson, D. M., Fick, C. A., & Gordon, S. E. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00915.2007 · Cited by 153
Belkaid, A., Currie, J.-C., Desgagnés, J., & Annabi, B. (2006) · Cancer Cell International · doi:10.1186/1475-2867-6-7 · Cited by 151
The Complexes of Mammalian Target of Rapamycin
Zhou, H., & Huang, S. (2010) · Current Protein & Peptide Science · doi:10.2174/138920310791824093 · Cited by 145
AMPK exerts dual regulatory effects on the PI3K pathway
Tao, R., Gong, J., Luo, X., Zang, M., Guo, W., Wen, R., & Luo, Z. (2010) · Journal of Molecular Signaling · doi:10.1186/1750-2187-5-1 · Cited by 141
Mammalian Target of Rapamycin: Hitting the Bull′s‐Eye for Neurological Disorders
Chong, Z. Z., Shang, Y. C., Zhang, L., Wang, S., & Maiese, K. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.6.14787 · Cited by 149
The Opposing Actions of Target of Rapamycin and AMP-Activated Protein Kinase in Cell Growth Control
Hindupur, S. K., González, A., & Hall, M. N. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019141 · Cited by 143
Wang, P., Zhou, Z., Hu, A., de Albuquerque, C. P., Zhou, Y., Hong, L., Sierecki, E., Ajiro, M., Kruhlak, M. J., Harris, C. C., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.007 · Cited by 161
Ribeiro, M., Rosenstock, T. R., Oliveira, A. M., Oliveira, C. R., & Rego, A. C. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.023 · Cited by 157
Carretero, J., Medina, P. P., Blanco, R., Smit, L., Tang, M., Roncador, G., Maestre, L., Conde, E., López‐Ríos, F., Clevers, H. C., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209951 · Cited by 156
Regulation of Autophagy and Its Associated Cell Death by “Sphingolipid Rheostat”
Taniguchi, M., Kitatani, K., Kondo, T., Hashimoto-Nishimura, M., Asano, S., Hayashi, A., Mitsutake, S., Igarashi, Y., Umehara, H., Takeya, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.416552 · Cited by 140
“Proliferative stimulation with growth factors activated Akt, which in turn phosphorylated mTOR (57).”
BackgroundEnergy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy
Troncoso, R., Vicencio, J. M., Parra, V., Nemchenko, A., Kawashima, Y., del Campo, A., Toro, B., Battiprolu, P. K., Aranguiz, P., Chiong, M., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr321 · Cited by 138
Kim, K.-Y., Baek, A., Hwang, J.-E., Choi, Y. A., Jeong, J., Lee, M.-S., Cho, D. H., Lim, J.-S., Kim, K. I., & Yang, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2641 · Cited by 137
AMPK and Raptor: Matching Cell Growth to Energy Supply
Hardie, D. G. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.012 · Cited by 138
Kaposi's Sarcoma–Associated Herpesvirus Confers a Survival Advantage to Endothelial Cells
Wang, L., & Damania, B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5988 · Cited by 141
Hou, G., Xue, L., Lu, Z., Fan, T., Tian, F., & Xue, Y. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.01.026 · Cited by 137
Thinking globally and acting locally with TOR
Arsham, A. M., & Neufeld, T. P. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.09.005 · Cited by 150
Chiang, M., Cheng, Y., Chen, S., Yen, C., & Huang, R. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.08.013 · Cited by 131
Liao, G., Gao, B., Gao, Y., Yang, X., Cheng, X., & Ou, Y. (2016) · Scientific Reports · doi:10.1038/srep34564 · Cited by 120
Kraegen, E. W., Saha, A. K., Preston, E., Wilks, D., Hoy, A. J., Cooney, G. J., & Ruderman, N. B. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00316.2005 · Cited by 124
Metadata
- Authors
- Hahn-Windgassen, A., Nogueira, V., Chen, C.-C., Skeen, J. E., Sonenberg, N., & Hay, N.
- Affiliations
- University of Illinois Chicago (US)
- McGill University (CA)
- Corresponding author
- Hay, Nissim
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 280
- Issue
- 37
- Pages
- 32081-32089
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2170704593
- Cited by
- 539
- References
- 50
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 9 · 2023: 17 · 2022: 24 · 2021: 33 · 2020: 26 · 2019: 27 · 2018: 21 · 2017: 27 · 2016: 26 · 2015: 38 · 2014: 25 · 2013: 42 · 2012: 35
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5504 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- Funders
- National Institute on Aging (R01AG016927, AG016927)
- National Cancer Institute (CA090764, R01CA090764)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007739)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- Akt, mTOR, AMPK, TSC2, AMP/ATP ratio, TSC2 phosphorylation, energy sensing
- MeSH terms
- Tuberous Sclerosis Complex 2 Protein, Adenine, Adenosine Triphosphate, Adenylate Kinase, Animals, Cells, Cultured, Dose-Response Relationship, Drug, Enzyme Activation, Gene Expression Regulation, Humans, Models, Biological, Phosphorylation, Plasmids, Protein Kinases, Proto-Oncogene Proteins, Repressor Proteins, Retroviridae, RNA, Messenger, Time Factors, Transfection, Protein Biosynthesis, Immunoblotting, Gene Expression Regulation, Enzymologic, Protein Serine-Threonine Kinases, Tumor Suppressor Proteins, Immunoprecipitation, Proto-Oncogene Proteins c-akt, Mice, Rats, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.